These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 3324264)
21. Tumor immunology: a neurosurgical perspective. II. The immunology of glial neoplasms. Apuzzo ML Bull Los Angeles Neurol Soc; 1976 Oct; 41(4):176-83. PubMed ID: 74264 [TBL] [Abstract][Full Text] [Related]
22. Ethanol inhibits prolactin- and tumor necrosis factor-alpha-, but not gamma interferon-induced expression of intercellular adhesion molecule-1 in human astrocytoma cells. DeVito WJ; Stone S; Mori K; Shamgochian M J Cell Biochem; 2000 Apr; 77(3):455-64. PubMed ID: 10760953 [TBL] [Abstract][Full Text] [Related]
23. In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes. Matsumoto Y; Hanawa H; Tsuchida M; Abo T Immunology; 1993 Jul; 79(3):381-90. PubMed ID: 7691723 [TBL] [Abstract][Full Text] [Related]
24. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. Ting CC; Rodrigues D J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653 [TBL] [Abstract][Full Text] [Related]
25. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224 [TBL] [Abstract][Full Text] [Related]
26. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy. Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722 [TBL] [Abstract][Full Text] [Related]
27. The effects of interleukin-6, leukemia inhibitory factor and interferon-gamma on STAT DNA binding and c-fos mRNA levels in cortical astrocytes and C6 glioma cells. Jenab S; Quinones-Jenab V Neuro Endocrinol Lett; 2002 Aug; 23(4):325-8. PubMed ID: 12195235 [TBL] [Abstract][Full Text] [Related]
28. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction. Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Perrone A; Barnaba V Immunology; 1994 Jun; 82(2):215-21. PubMed ID: 7927492 [TBL] [Abstract][Full Text] [Related]
30. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
31. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077 [TBL] [Abstract][Full Text] [Related]
32. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study. Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275 [TBL] [Abstract][Full Text] [Related]
33. Neuroimmunology. II: Antigenic specificity of the nervous system. Weiner HL; Hauser SL Ann Neurol; 1982 Dec; 12(6):499-509. PubMed ID: 6186183 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies reactive with epitopes restricted to glial fibrillary acidic proteins of several species. Pegram CN; Eng LF; Wikstrand CJ; McComb RD; Lee YL; Bigner DD Neurochem Pathol; 1985; 3(2):119-38. PubMed ID: 2413405 [TBL] [Abstract][Full Text] [Related]
35. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Schmits R; Cochlovius B; Treitz G; Regitz E; Ketter R; Preuss KD; Romeike BF; Pfreundschuh M Int J Cancer; 2002 Mar; 98(1):73-7. PubMed ID: 11857388 [TBL] [Abstract][Full Text] [Related]
36. Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets. Cairncross JG; Mattes MJ; Beresford HR; Albino AP; Houghton AN; Lloyd KO; Old LJ Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5641-5. PubMed ID: 6182568 [TBL] [Abstract][Full Text] [Related]
37. Immunology of central nervous system tumors. de Micco C J Neuroimmunol; 1989 Dec; 25(2-3):93-108. PubMed ID: 2685042 [TBL] [Abstract][Full Text] [Related]
38. Antigenic phenotypes of cultured malignant astrocytomas: identification of lineage-consistent, lineage-independent and putative tumor-restricted antigenic expression. Jennings MT; Jennings VD; Asadourian LL; Ebrahim SA; Klein CE; Old LJ J Neurol Sci; 1989 Jan; 89(1):79-92. PubMed ID: 2926444 [TBL] [Abstract][Full Text] [Related]
39. Immunobiology of malignant gliomas. Tada M; de Tribolet N J Clin Neurosci; 1996 Apr; 3(2):102-13. PubMed ID: 18638850 [TBL] [Abstract][Full Text] [Related]